🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, claiming the firms withheld safety concerns that the drug created to children's neurological development.

This legal action follows thirty days after Former President Trump publicized an unverified association between using Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the exclusive pain medication approved for women during pregnancy, and Kenvue, which currently produces it.

In a declaration, he stated they "deceived the public by gaining financially from suffering and pushing pills ignoring the dangers."

The manufacturer states there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These companies misled for generations, deliberately risking millions to boost earnings," Paxton, from the Republican party, declared.

The manufacturer said in a statement that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its official site, the company also said it had "consistently assessed the applicable studies and there is no credible data that demonstrates a proven link between using acetaminophen and autism."

Associations representing doctors and healthcare providers agree.

The leading OB-GYN organization has stated paracetamol - the primary component in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can present significant medical dangers if ignored.

"In multiple decades of research on the use of paracetamol in gestation, no reliable research has definitively established that the consumption of acetaminophen in any period of pregnancy results in neurological conditions in young ones," the organization stated.

This legal action cites current declarations from the former administration in claiming the medication is reportedly hazardous.

Last month, the former president generated worry from health experts when he advised pregnant women to "resist strongly" not to use Tylenol when unwell.

The FDA then issued a notice that physicians should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in young ones has not been established.

Health Secretary Kennedy, who manages the Food and Drug Administration, had pledged in April to initiate "extensive scientific investigation" that would establish the source of autism in a matter of months.

But authorities advised that finding a single cause of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and impairment that influences how persons experience and relate to the environment, and is identified using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is campaigning for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism.

This legal action attempts to require the companies "eliminate any commercial messaging" that states acetaminophen is reliable for women during pregnancy.

The court case echoes the concerns of a assembly of parents of children with autism spectrum disorder and ADHD who sued the makers of acetaminophen in two years ago.

A federal judge rejected the legal action, declaring investigations from the plaintiffs' authorities was not conclusive.